Literature DB >> 9376963

Magnetization transfer imaging in AIDS-related brain diseases.

V Dousset1, J P Armand, P Huot, B Viaud, J M Caille.   

Abstract

MT makes it possible to characterize tissue destruction in several CNS diseases, including AIDS-related diseases such as PML or HIV encephalitis. MR may be helpful in establishing diagnosis, disease burden, prognosis, and therapeutic efficacy. MT may also contribute to the investigation of the natural history of the diseases. The other application is in improving contrast after the injection of gadolinium chelates. This contrast improvement can be achieved routinely on any device and may be a good alternative to other methods, such as increasing dose or delay.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376963

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  5 in total

1.  Whole brain diffusion tensor imaging in HIV-associated cognitive impairment.

Authors:  Ann B Ragin; Pippa Storey; Bruce A Cohen; Leon G Epstein; Robert R Edelman
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

2.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 3.  HIV/neuroAIDS biomarkers.

Authors:  Pejman Rahimian; Johnny J He
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

4.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

5.  Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures.

Authors:  A B Ragin; P Storey; B A Cohen; R R Edelman; L G Epstein
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.